Skip to Main Content

electroCore, Inc. Common Stock

ECOR Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ECOR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ECOR Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ECOR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ECOR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ECOR holdings by institutional investors

Quarterly net insider trading by ECOR's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

ECOR Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ECOR Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ECOR Income Statement
ECOR Balance Sheet
ECOR Cash Flow
U.S. Patents

New ECOR patent grants

  • Patent Title: Nerve stimulation device Aug. 26, 2025
  • Patent Title: Electrical treatment of bronchial constriction Nov. 21, 2017
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Aug. 01, 2017
  • Patent Title: Nerve stimulator system May. 23, 2017
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Apr. 18, 2017
  • Patent Title: Systems and methods for vagal nerve stimulation Feb. 14, 2017
  • Patent Title: Non-invasive treatment of bronchial constriction Jan. 31, 2017
  • Patent Title: Systems and methods for electrical stimulation of sphenopalatine ganglion and other branches of cranial nerves Oct. 18, 2016
  • Patent Title: Devices and methods for treating medical disorders with evoked potentials and vagus nerve stimulation Aug. 30, 2016
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Aug. 16, 2016
  • Patent Title: Non-invasive magnetic or electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders Aug. 02, 2016
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Jul. 26, 2016
  • Patent Title: Mobile phone using non-invasive nerve stimulation Jun. 28, 2016
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Jun. 07, 2016
  • Patent Title: Electrical stimulation treatment of hypotension May. 17, 2016
  • Patent Title: Devices and methods for non-invasive electrical stimulation and their use for vagal nerve stimulation on the neck of a patient May. 10, 2016
  • Patent Title: Non-invasive treatment of bronchial constriction May. 03, 2016
  • Patent Title: Methods and apparatus for treating anaphylaxis using electrical modulation Mar. 15, 2016
  • Patent Title: Devices and methods for monitoring non-invasive vagus nerve stimulation Feb. 09, 2016
  • Patent Title: Medical self-treatment using non-invasive vagus nerve stimulation Feb. 02, 2016
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Jan. 26, 2016
  • Patent Title: Magnetic stimulation devices and methods of therapy Jan. 12, 2016
  • Patent Title: Methods and devices for treating primary headache Jan. 12, 2016
  • Patent Title: Non-invasive magnetic or electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders Jan. 12, 2016
  • Patent Title: Nerve stimulator system Dec. 08, 2015
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Nov. 03, 2015
  • Patent Title: Systems and methods for electrical stimulation of sphenopalatine ganglion and other branches of cranial nerves Nov. 03, 2015
  • Patent Title: Non-invasive electrical and magnetic nerve stimulators used to treat overactive bladder and urinary incontinence Nov. 03, 2015
  • Patent Title: Non-invasive vagus nerve stimulation devices and methods to treat or avert atrial fibrillation Sep. 08, 2015
  • Patent Title: Non-invasive treatment of a medical condition by vagus nerve stimulation Sep. 01, 2015
  • Patent Title: Non-invasive methods and devices for inducing euphoria in a patient and their therapeutic application Jul. 28, 2015
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Jun. 30, 2015
  • Patent Title: Methods and devices for treating primary headache May. 26, 2015
  • Patent Title: Non-invasive treatment of bronchial constriction May. 19, 2015
  • Patent Title: Electrical stimulation treatment of bronchial constriction May. 19, 2015
  • Patent Title: Methods and devices for treating primary headache Apr. 28, 2015
  • Patent Title: Methods and devices for treating primary headache Apr. 21, 2015
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Mar. 17, 2015
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Mar. 17, 2015
  • Patent Title: Magnetic stimulation devices and methods of therapy Mar. 03, 2015
  • Patent Title: Electrical stimulation treatment of hypotension Feb. 03, 2015
  • Patent Title: Methods and apparatus for treating anaphylaxis using electrical modulation Jan. 13, 2015
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Dec. 23, 2014
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Dec. 16, 2014
  • Patent Title: Systems and methods for selectively applying electrical energy to tissue Nov. 04, 2014
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Oct. 28, 2014
  • Patent Title: Device and methods for non-invasive electrical stimulation and their use for vagal nerve stimulation Oct. 28, 2014
  • Patent Title: Non-invasive treatment of neurodegenerative diseases Oct. 21, 2014
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Sep. 23, 2014
  • Patent Title: Stimulator Oct. 16, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ECOR from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ECOR News

Recent insights relating to ECOR

CNBC Recommendations

Recent picks made for ECOR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ECOR

ECOR Analyst Ratings

ECOR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ECOR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ECOR stock a Buy, Sell, or Hold?

  • What is the price target for $ECOR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ECOR Top Shareholders
Shareholder
Shares Held
ECOR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ECOR stock?

  • Who owns the most shares of $ECOR stock?

  • What funds own $ECOR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ECOR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ECOR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ECOR

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

  • Address Rockaway, NJ
  • Market Cap 37.7 million
  • Employees 62
  • Industrial Classification Electromedical & Electrotherapeutic Apparatus
Back To Top